Becker's Healthcare March 27, 2024
On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition.
Merck said it expects sotatercept-csrk, which goes by the brand name Winrevair, to be available at select specialty pharmacies in the U.S. by the end of April. While there are other drugs that manage symptoms for patients with PAH, the approval marks the first for a medicine that targets the root cause of the condition....
Today's Sponsors
Today's Sponsor